There are more than 180 million individuals in the world who are blind or at serious risk of becoming blind, yet many causes of blindness that include cataracts and glaucoma can potentially be prevented or treated. Still others, like macular degeneration and diabetic retinopathy, need much more exploration. The World Health Organization estimates that, globally, up to 75 percent of all blindness is avoidable. Of the more than 45 million people worldwide who have actually lost their sight, more than 82 percent are 50 years of age and older, with cataracts being the leading cause of blindness. The fact that many populations across the globe are demographically shifting toward the predominance of older age groups translates to an ever-increasing number of people at risk for visual impairment in the future. This larger aging population and increased life spans also increases the potential of other blinding eye conditions such as age-related macular degeneration (AMD), diabetic retinopathy and glaucoma. Decelerating these trends will require much effort, but Alcon is prepared to tackle the task, as we believe that a better quality of life for the world begins with the eye care needs of communities across the globe. The world of eye health
Learn about the world of eye health as Alcon sees it – how things are today and what we hope tomorrow will bring. Through a global approach, implemented on a local level, Alcon's approach to the treatment of numerous eye conditions and diseases starts with knowledge of the disease itself and includes education for physicians in areas where the conditions are prevalent. Through our understanding of eye-related diseases and conditions and our strong relationships with physicians, we are in a position to make a positive impact on the state of eye health worldwide.
Alcon started operation in India in the year 1989 selling its surgical products through distribution Viz. Rampion Eyetech Pvt Ltd., Ahmedhabad. Considering the potential growth of the ophthalmic business in India, Alcon set up a Liaison office in India in 1996. Alcon appointed Rampion Eyetech Pvt Ltd. as exclusive distribution for selling Alcon products in India. In The year 2000, Alcon started operating as fully owned subsidiary in India as- Alcon Laboratories India Pvt Ltd. managing the entire business for India. In the year 2004 the pharmaceuticals business unit was set up in India for the first time with this Alcon has two business units operating in India namely Surgical & Instrumentation and pharmaceuticals. India is the second most populous and seventh largest country in the world. It comprises of 28 states and 7 centrally administered union territories. There are wide variations amongst the states, which were constituted on linguistic basis, with varied size, level of economic development and cultures. The population of the country rose by 21.34 % between 1991 and 2001. It is estimated that there are between 15 ‐ 18.6 million people with blindness in India using the Indian definition and the visual field as a criteria, which amounts to about one fourth of the world’s blind population. 3.1 Magnitude and Prevalence of Blindness India houses highest percentage of cataract population of the world as well as high cataract prevalence rate. It was estimated that in India 3.8 million people become blind from cataract each year in the early nineties. Blindness in India is known to increase rapidly after 50 years of age. Nearly half of the world's micronutrient deficient people may be found in India. For example, of the 20‐40 million children worldwide who are estimated to have at least mild vitamin A deficiency (VAD), half reside in India. VAD causes an estimated 60,000 children in India to go blind each year. As per the National Survey records, the States like Madhya Pradesh, Rajasthan and Jammu & Kashmir have high blindness prevalence (2% and...
Please join StudyMode to read the full document